Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258–70.
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72.
Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164(6):659–63.
Wen CP, Cheng TYD, Tsai MK, Chang YC, Chan HT, Tsai SP, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet. 2008;371(9631):2173–82.
Levey A, Atkins R, Coresh J, Cohen E, Collins A, Eckardt K-U, et al. Chronic kidney disease as a global public health problem: approaches and initiatives–a position statement from kidney disease improving global outcomes. Kidney Int. 2007;72(3):247–59.
Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–81.
Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2020;395(10225):709–33.
Australian Institute of Health Welfare. Chronic kidney disease prevalence among Australian adults over time. Canberra: AIHW; 2018.
Australian Institute of Health Welfare. Chronic kidney disease: Australian facts. Canberra: AIHW; 2023.
Hayashi T, Kimura T, Yasuda K, Sasaki K, Obi Y, Nagayama H, et al. Early nephrology referral 6 months before dialysis initiation can reduce early death but does not improve long-term cardiovascular outcome on dialysis. Circ J. 2016;80(4):1008–16.
Sabath E, Vega O, Correa-Rotter R. Early referral to the nephrologist: impact on initial hospitalization and the first 6 months of continuous ambulatory peritoneal dialysis. Rev Invest Clin. 2003;55(5):489–93.
Huisman RM. The deadly risk of late referral. Nephrol Dial Transpl. 2004;19(9):2175–80.
Smart NA, Titus TT. Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review. Am J Med. 2011;124(11):1073–e802.
Sharif MU, Elsayed ME, Stack AG. The global nephrology workforce: emerging threats and potential solutions! Clin Kidney J. 2016;9(1):11–22.
Bello AK, Levin A, Manns BJ, Feehally J, Drueke T, Faruque L, et al. Effective CKD care in European countries: challenges and opportunities for health policy. Am J Kidney Dis. 2015;65(1):15–25.
Parker MG, Ibrahim T, Shaffer R, Rosner MH, Molitoris BA. The future nephrology workforce: will there be one? Clin J Am Soc Nephrol. 2011;6(6):1501–6.
Mehrotra R, Shaffer RN, Molitoris BA, editors. Implications of a nephrology workforce shortage for dialysis patient care. Semin Dial; 2011.
Katz IJ, Gerntholtz T, Naicker S. Africa and nephrology: the forgotten continent. Nephron Clin Pract. 2011;117(4):320–7.
Osman MA, Alrukhaimi M, Ashuntantang GE, Bellorin-Font E, Gharbi MB, Braam B, et al. Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system. Kidney Int Suppl. 2018;8(2):52–63.
Sozio SM, Pivert KA, Caskey FJ, Levin A. The state of the global nephrology workforce: a joint ASN–ERA-EDTA–ISN investigation. Kidney Int. 2021;100(5):995–1000.
Australian and New Zealand Society of Nephrology. Report of the Workforce Review Committee of the Australian and New Zealand Society of Nephrology: Australian and New Zealand Society of Nephrology; 2017. https://www.nephrology.edu.au/workforce-report.asp.
Amos L, Toussaint N, Phoon R, Elias T, Levidiotis V, Campbell S, et al. Increase in nephrology advanced trainee numbers in Australia and associated reduction in clinical exposure over the past decade. Intern Med J. 2013;43(3):287–93.
Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco AL, De Jong PE, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1–150.
Martinez YV, Benett I, Lewington AJ, Wierzbicki AS. Chronic kidney disease: summary of updated NICE guidance. BMJ. 2021;374.
Johnson DW, CARI Guidelines. When to refer for specialist renal care. 2012 [updated May 2013. https://www.cariguidelines.org/guidelines/chronic-kidney-disease/early-chronic-kidney-disease/when-to-refer-for-specialist-renal-care/.
Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet. 2016;388(10041):294–306.
Saran R, Robinson B, Abbott KC, Agodoa LY, Bhave N, Bragg-Gresham J, et al. US renal data system 2017 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2018;71(3):A7.
Lonnemann G, Duttlinger J, Hohmann D, Hickstein L, Reichel H. Timely referral to outpatient nephrology care slows progression and reduces treatment costs of chronic kidney diseases. Kidney Int Rep. 2017;2(2):142–51.
Chen JH, Chiu YW, Hwang SJ, Tsai JC, Shi HY, Lin MY. Effect of nephrology referrals and multidisciplinary care programs on renal replacement and medical costs on patients with advanced chronic kidney disease: a retrospective cohort study. Medicine. 2019;98(33):e16808.
Dharod A, Bundy R, Russell GB, Rice WY 3rd, Golightly CE, Rosenthal GE, et al. Primary care referrals to nephrology in patients with advanced kidney disease. Am J Manag Care. 2020;26(11):468–74.
Campbell GA, Bolton WK. Referral and comanagement of the patient with CKD. Adv Chronic Kidney Dis. 2011;18(6):420–7.
Haley WE, Beckrich AL, Sayre J, McNeil R, Fumo P, Rao VM, et al. Improving care coordination between nephrology and primary care: a quality improvement initiative using the renal physicians association toolkit. Am J Kidney Dis. 2015;65(1):67–79.
Samal L, Wright A, Waikar SS, Linder JA. Nephrology co-management versus primary care solo management for early chronic kidney disease: a retrospective cross-sectional analysis. BMC Nephrol. 2015;16(1):1–8.
Baer G, Lameire N, Van Biesen W. Late referral of patients with end-stage renal disease: an in-depth review and suggestions for further actions. NDT plus. 2010;3(1):17–27.
Kessler M, Frimat L, Panescu V, Briançon S. Impact of nephrology referral on early and midterm outcomes in ESRD: EPidémiologie De l’Insuffisance REnale Chronique terminale en Lorraine (EPIREL): results of a 2-year, prospective, community-based study. Am J Kidney Dis. 2003;42(3):474–85.
Chan MR, Dall AT, Fletcher KE, Lu N, Trivedi H. Outcomes in patients with chronic kidney disease referred late to nephrologists: a meta-analysis. Am J Med. 2007;120(12):1063–70.
Diegoli H, Silva MC, Machado DS, Cruz CE. Late nephrologist referral and mortality assotiation in dialytic patients. J Bras Nefrol. 2015;37(1):32–7.
Anees M, Hussain Y, Ibrahim M, Ilahi I, Ahmad S, Asif KI, et al. Outcome of chronic kidney disease patients on the basis of referral to nephrologist: a one-year follow-up study. J Coll Physicians Surg Pak. 2018;28(4):304–7.
Wavamunno MD, Harris DC. The need for early nephrology referral. Kidney Int Suppl. 2005;94:S128–32.
Winkelmayer WC, Owen WF, Levin R, Avorn J. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol. 2003;14(2):486–92.
Hughes SA, Mendelssohn JG, Tobe SW, McFarlane PA, Mendelssohn DC. Factors associated with suboptimal initiation of dialysis despite early nephrologist referral. Nephrol Dial Transpl. 2013;28(2):392–7.
Levin A, Stevens PE. Early detection of CKD: the benefits, limitations and effects on prognosis. Nat Rev Nephrol. 2011;7(8):446–57.
Greenhalgh T, Thorne S, Malterud K. Time to challenge the spurious hierarchy of systematic over narrative reviews? Eur J Clin Invest. 2018;48(6).
Ferrari R. Writing narrative style literature reviews. Med Writ. 2015;24(4):230–5.
Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the conduct of narrative synthesis in systematic reviews. Prod ESRC Methods Programme Version. 2006;1(1):b92.
Fletcher KE, Underwood W, Davis SQ, Mangrulkar RS, McMahon LF, Saint S. Effects of work hour reduction on residents’ lives: a systematic review. JAMA. 2005;294(9):1088–100.
Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3):21–35.
Stroupe KT, Fischer MJ, Kaufman JS, O’Hare AM, Sohn MW, Browning MM, et al. Predialysis nephrology care and costs in elderly patients initiating dialysis. Med Care. 2011;49(3):248–56.
Kim DH, Kim M, Kim H, Kim Y-L, Kang S-W, Yang CW, et al. Early referral to a nephrologist improved patient survival: prospective cohort study for end-stage renal disease in Korea. PLoS ONE. 2013;8(1):e55323–e.
Smart NA, Dieberg G, Ladhani M, Titus T. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease. Cochrane Database Syst Rev. 2014(6):CD007333.
Gillespie BW, Morgenstern H, Hedgeman E, Tilea A, Scholz N, Shearon T, et al. Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USA. Clin Kidney J. 2015;8(6):772–80.
Avorn J, Winkelmayer WC, Bohn RL, Levin R, Glynn RJ, Levy E, et al. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol. 2002;55(7):711–6.
Thilly N, Boini S, Loos-Ayav C, Kessler M, Briançon S, Frimat L. Impact of predialysis therapeutic practices on patient outcomes during the first year of dialysis: the Pharmacoepidemiologic AVENIR study. Med Care. 2012:35–42.
Hasegawa T, Bragg-Gresham JL, Yamazaki S, Fukuhara S, Akizawa T, Kleophas W, et al. Greater first-year survival on hemodialysis in facilities in which patients are provided earlier and more frequent pre-nephrology visits. Clin J Am Soc Nephrol. 2009;4(3):595–602.
Khan SS, Xue JL, Kazmi WH, Gilbertson DT, Obrador GT, Pereira BJ, et al. Does predialysis nephrology care influence patient survival after initiation of dialysis? Kidney Int. 2005;67(3):1038–46.
Singhal R, Hux JE, Alibhai SM, Oliver MJ. Inadequate predialysis care and mortality after initiation of renal replacement therapy. Kidney Int. 2014;86(2):399–406.
Foley RN, Chen S-C, Solid CA, Gilbertson DT, Collins AJ. Early mortality in patients starting dialysis appears to go unregistered. Kidney Int. 2014;86(2):392–8.
Fischer MJ, Stroupe KT, Kaufman JS, O’Hare AM, Browning MM, Sohn MW, et al. Predialysis nephrology care and dialysis-related health outcomes among older adults initiating dialysis. BMC Nephrol. 2016;17(1):103.
Major RW, Shepherd D, Medcalf JF, Xu G, Gray LJ, Brunskill NJ. The kidney failure risk equation for prediction of end stage renal disease in UK primary care: an external validation and clinical impact projection cohort study. PLoS Med. 2019;16(11):e1002955.
Duggal V, Montez-Rath ME, Thomas IC, Goldstein MK, Tamura MK. Nephrology referral based on laboratory values, kidney failure risk, or both: a study using veterans affairs health system data. Am J Kidney Dis. 2021.
Bhachu HK, Cockwell P, Subramanian A, Adderley NJ, Gokhale K, Fenton A, et al. Impact of using risk-based stratification on referral of patients with chronic kidney disease from primary care to specialist care in the United Kingdom. Kidney Int Rep. 2021;6(8):2189–99.
World Health Organization. Referral Systems-a summary of key processes to guide health services managers: Geneva, Switzerland: Author. 2013. https://studylib.net/doc/7906949/referral-systems—a-summary-of-key-processes-to-guide-health.
Stack AG. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis. 2003;41(2):310–8.
Roderick P, Jones C, Drey N, Blakeley S, Webster P, Goddard J, et al. Late referral for end-stage renal disease: a region-wide survey in the south west of England. Nephrol Dial Transpl. 2002;17(7):1252–9.
Ravani P, Quinn R, Fiocco M, Liu P, Al-Wahsh H, Lam N, et al. Association of age with risk of kidney failure in adults with stage IV chronic kidney disease in Canada. JAMA Netw Open. 2020;3(9):e2017150–e.
Jose MD, Raj R, Jose K, Kitsos A, Saunder T, McKercher C, et al. Competing risks of death and kidney failure in a cohort of Australian adults with severe chronic kidney disease. Med J Aust. 2022;216(3):140–6.
Djukanović L, Lezaic V, Dimković N, Peruničić Peković G, Bukvić D, Bajčetić S, et al. Early detection of chronic kidney disease: collaboration of Belgrade nephrologists and primary care physicians. Nefrologia (Engl Ed). 2012;32(1):59–66.
Mathew T, Corso O. Early detection of chronic kidney disease in Australia: which way to go? Nephrology. 2009;14(4):367–73.
Gansevoort RT, Bakker SJ, De Jong PE. Early detection of progressive chronic kidney disease: is it feasible? J Am Soc Nephrol. 2006;17(5):1218–20.
Black C, Sharma P, Scotland G, McCullough K, McGurn D, Robertson L, et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess. 2010;14(21):1–184.
Winkelmayer WC, Liu J, Chertow GM, Tamura MK. Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med. 2011;171(15):1371–8.
Lee J, Lee JP, Park JI, Hwang JH, Jang HM, Choi JY, et al. Early nephrology referral reduces the economic costs among patients who start renal replacement therapy: a prospective cohort study in Korea. PLoS ONE. 2014;9(6):e99460.
Kazmi WH, Obrador GT, Khan SS, Pereira BJ, Kausz AT. Late nephrology referral and mortality among patients with end-stage renal disease: a propensity score analysis. Nephrol Dial Transpl. 2004;19(7):1808–14.
Selim G, Stojceva-Taneva O, Spasovski G, Tozija L, Grozdanovski R, Georgievska-Ismail L, et al. Timing of nephrology referral and initiation of dialysis as predictors for survival in hemodialysis patients: 5-year follow-up analysis. Int Urol Nephrol. 2015;47(1):153–60.
Kim DH, Kim M, Kim H, Kim YL, Kang SW, Yang CW, et al. Early referral to a nephrologist improved patient survival: prospective cohort study for end-stage renal disease in Korea. PLoS ONE. 2013;8(1):e55323.
Nakamura S, Nakata H, Yoshihara F, Kamide K, Horio T, Nakahama H, et al. Effect of early nephrology referral on the initiation of hemodialysis and survival in patients with chronic kidney disease and cardiovascular diseases. Circ J. 2007;71(4):511–6.
Obrador GT, Pereira B. Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis. 1998;31(3):398–417.
Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data. Ann Intern Med. 2001;135(2):73–87.
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851–60.
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89.
Ravani P, Marinangeli G, Tancredi M, Malverti F. Multidisciplinary chronic kidney disease management improves survival on dialysis. J Nephrol. 2003;16(6):870–7.
Levin A, Lewis M, Mortiboy P, Faber S, Hare I, Porter EC, et al. Multidisciplinary predialysis programs: quantification and limitations of their impact on patient outcomes in two Canadian settings. Am J Kidney Dis. 1997;29(4):533–40.
Buck J, Baker R, Cannaby A-M, Nicholson S, Peters J, Warwick G. Why do patients known to renal services still undergo urgent dialysis initiation? A cross-sectional survey. Nephrol Dial Transpl. 2007;22(11):3240–5.
Crews DC, Jaar BG, Plantinga LC, Kassem HS, Fink NE, Powe NR. Inpatient hemodialysis initiation: reasons, risk factors and outcomes. Nephron Clin Pract. 2010;114(1):c19–28.
Marrón B, Ortiz A, de Sequera P, Martín-Reyes G, de Arriba G, Lamas JM, et al. Impact of end-stage renal disease care in planned dialysis start and type of renal replacement therapy—a Spanish multicentre experience. Nephrol Dial Transpl. 2006;21(suppl2):ii51–5.
Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol. 2004;15(2):477–86.
Quinn RR, Oliver MJ, Devoe D, Poinen K, Kabani R, Kamar F, et al. The effect of predialysis fistula attempt on risk of all-cause and access-related death. J Am Soc Nephrol. 2017;28(2):613–20.
Tang TT, Levin ML, Ahya SN, Boobes K, Hasan MH. Initiation of maintenance hemodialysis through central venous catheters: study of patients’ perceptions based on a structured questionnaire. BMC Nephrol. 2019;20(1):1–6.
Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465–73.
Xue JL, Peter WLS, Ebben JP, Everson SE, Collins AJ. Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. Am J Kidney Dis. 2002;40(6):1153–61.
Rognant N, Laville M. Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought. Kidney Int. 2014;86(2):238–40.
Chu CD, Lamprea-Montealegre JA, Estrella MM. Too many for too few: finding appropriate nephrology referrals for patients with CKD that optimize outcomes. Am J Kidney Dis. 2022;79(3):330–2.
Singh K, Waikar SS, Samal L. Evaluating the feasibility of the KDIGO CKD referral recommendations. BMC Nephrol. 2017;18(1):223.
Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012;307(18):1941–51.
Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369(10):932–43.
Oliva-Damaso N, Delanaye P, Oliva-Damaso E, Payan J, Glassock RJ. Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease. Clin Kidney J. 2022;15(11):1996–2005.
NICE Guideline. Evidence review for the best combination of measures to identify increased risk of progression in adults, children and young people. London: National Institute for Health and Care Excellence; 2021. p. 203. Report No.
Hingwala J, Wojciechowski P, Hiebert B, Bueti J, Rigatto C, Komenda P, et al. Risk-based triage for nephrology referrals using the kidney failure risk equation. Can J Kidney Health Dis. 2017;4:2054358117722782.
- The Renal Warrior Project. Join Now
- Source: https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-024-03585-z